Isoquinoline derivatives and their use as gfat inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 217/18 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61P 3/10 (2006.01) C07D 217/22 (2006.01) C07D 217/26 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 405/10 (2006.01) C07D 409/10 (2006.01) C07D 413/06 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2524958

Compounds of formula (I) are provided as well as pharmaceutically acceptable salts and esters thereof, wherein the substituents are as disclosed in the specification. The compounds have utility for the treatment of type 2 diabetes mellitus.

L'invention porte sur des composés de formule (I) et sur leurs sels et esters pharmacocompatibles, dont les substituants sont définis dans les spécifications. Lesdits composés sont utiles pour le traitement du diabète sucré de type 2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoquinoline derivatives and their use as gfat inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoquinoline derivatives and their use as gfat inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives and their use as gfat inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1485852

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.